James Condulis
Stock Analyst at Stifel Nicolaus
(0.69)
# 4,165
Out of 5,043 analysts
64
Total ratings
30.2%
Success rate
-4.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $45 | $28.14 | +59.91% | 3 | Oct 1, 2026 | |
| BRVE Braveheart Bio | Reiterated: Buy | $45 | $20.02 | +124.78% | 4 | Oct 1, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $75 | $23.33 | +221.47% | 4 | Oct 1, 2026 | |
| ACHV Achieve Life Sciences | Initiated Coverage: Buy | $18 | $7.41 | +142.91% | 1 | Sep 30, 2026 | |
| FULC Fulcrum Therapeutics | Rated: Hold | n/a | $3.77 | - | 6 | Sep 21, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | $50 | $21.58 | +131.75% | 6 | Sep 8, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $104 | $62.75 | +65.74% | 3 | Aug 31, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 | $4.76 | +26.05% | 5 | Aug 13, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Hold | $36 | $39.06 | -7.83% | 6 | Aug 11, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $108 | $62.91 | +71.67% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.91 | +243.64% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 | $86.01 | +58.12% | 8 | Aug 6, 2026 |
Amylyx Pharmaceuticals
Oct 1, 2026
Reiterated: Buy
Price Target: $45
Current: $28.14
Upside: +59.91%
Braveheart Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $45
Current: $20.02
Upside: +124.78%
Tectonic Therapeutic
Oct 1, 2026
Reiterated: Buy
Price Target: $75
Current: $23.33
Upside: +221.47%
Achieve Life Sciences
Sep 30, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $7.41
Upside: +142.91%
Fulcrum Therapeutics
Sep 21, 2026
Rated: Hold
Price Target: n/a
Current: $3.77
Upside: -
NewAmsterdam Pharma Company
Sep 8, 2026
Reiterated: Buy
Price Target: $50
Current: $21.58
Upside: +131.75%
Arrowhead Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $104
Current: $62.75
Upside: +65.74%
Aardvark Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $6
Current: $4.76
Upside: +26.05%
Edgewise Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $36
Current: $39.06
Upside: -7.83%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $108
Current: $62.91
Upside: +71.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.91
Upside: +243.64%
Aug 6, 2026
Reiterated: Buy
Price Target: $136
Current: $86.01
Upside: +58.12%